Details

NameSymbolSector
GLENMARK PHARMACEUTICALS LTDGLENMARKPharmaceuticals
Open
2328.1
High
2427.4
Low
2327.3
Close
2403.7
Volume
1537658
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Glenmark Pharmaceuticals is  
Long Body
Estimated Stoploss of Glenmark Pharmaceuticals is ₹  
2327.3
Glenmark Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Glenmark Pharmaceuticals maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Glenmark Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glenmark Pharmaceuticals is  
Upℹ
 by  

10.99

%. 
Target
Buy @ 

1899.76

Sell @ 

2327.1

Current @ 

2403.7

Volume

The trades of Glenmark Pharmaceuticals have been in  
Immenseℹ
 volume. 
The volume trades for Glenmark Pharmaceuticals are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Glenmark Pharmaceuticals is  

Up

 by  

155.51

% 

Valuation

The current market price of Glenmark Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 16049cr and total assets worth ₹ 16049cr, the balance sheet of Glenmark Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glenmark Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Downℹ
 by  

92.09

%. 

(*Mar 2025)

49.49% i.e. ₹ 827cr spent in operatingℹ
0.12% i.e. ₹ 2cr earned in investingℹ
47.1% i.e. ₹ 787cr earned in financingℹ
3.29% i.e. ₹ 55cr earned in otherℹ
Glenmark Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 215cr

. It is  
Upℹ
 by  

571.88

%. 

(*Mar 2024)

2.98% i.e. ₹ 265cr spent in operatingℹ
51.21% i.e. ₹ 4560cr earned in investingℹ
43.86% i.e. ₹ 3906cr spent in financingℹ
1.95% i.e. ₹ 174cr spent in otherℹ
Income
The income of Glenmark Pharmaceuticals is  

₹ 6247cr

 and  

Profit

 is :  

₹ 610cr

(*Sep 2025)

Glenmark Pharmaceuticals Profit is up by:  

1226.09

% and Income is Up by:  

89.88

% 

(*Sep 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3290cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Glenmark Pharmaceuticals Profit is up by:  

1050

% and Income is Up by:  

0.7

% 

(*Jun 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3267cr

 and  

Profit

 is :  

₹ 4cr

(*Mar 2025)

Glenmark Pharmaceuticals Profit is down by:  

98.85

% and Income is Down by:  

4.42

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.